Sign In
Free Newsletter
Manning defends U.Va. negotiations with DOJ
Charlottesville investor and University of Virginia board member Paul B. Manning sent a letter Monday to U.Va.'s Faculty Senate and fellow board members defending his actions in university negotiations with the U.S. Department of Justice.
U.Va. hires AstraZeneca exec to lead Manning biotech institute
Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and Diane Manning Institute of Biotechnology at the University of Virginia, U.Va. announced Thursday. Esser, who will join U.Va. May 1, earned a Ph.D. in microbiology in 1998 from […]
